We are pleased to announce that the NINDS Clinical Trials Methodology Course (CTMC) is accepting applications for the 2020 cohort. The overarching goal of the CTMC is to help junior investigators develop scientifically rigorous, yet practical clinical trial protocols.
The course features a combination of distance learning activities and a residential course, along with small group mentorship from experienced clinical trialists and biostatisticians. Investigators from the NeuroNEXT and Strategies to Innovate Emergency Care (SIREN) clinical trials networks, along with other clinical trials experts, lead this course and serve as faculty. The residential part of the course is required and will be held July 20 – 23, 2020 in Ann Arbor, MI. Funding for travel (within the US) and accommodations will be provided for participants. Qualified applicants from clinical disciplines focused on neurological disease or injury, along with biostatisticians working on projects with clinical neuroscience researchers are encouraged to apply. All preliminary trial ideas are encouraged – the only requirement is that protocols are focused on the clinical neurosciences. Trainees should have content area mentors to assist them with the science and implementation of their project.
The deadline for application submission is February 28, 2020 at midnight. Application forms and additional details are available on the course website https://nett.umich.edu/training/ctmc.
Please contact NINDS-CTMC-Info@umich.edu or William Meurer, MD, MS with any questions wmeurer@umich.edu.
The NINDS Clinical Trials Methodology Course is supported by the NIH-NINDS grant R25 NS088248 and is administered by the University of Michigan, the University of Iowa, and Los Angeles BioMed. Additional support is provided by the American Academy of Neurology.